- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Results
8
8 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.8b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.88
7D
-2.1%
1Y
-20.8%
Tong Ren Tang Technologies
Market Cap: HK$4.6b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.49
7D
-1.4%
1Y
-32.9%
Jacobson Pharma
Market Cap: HK$2.2b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.11
7D
-1.8%
1Y
-14.0%
Shandong Xinhua Pharmaceutical
Market Cap: HK$8.6b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$5.78
7D
-4.5%
1Y
-8.4%
Essex Bio-Technology
Market Cap: HK$1.6b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.70
7D
-10.0%
1Y
-45.5%
China Shineway Pharmaceutical Group
Market Cap: HK$6.4b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.44
7D
-0.5%
1Y
8.1%
Pak Fah Yeow International
Market Cap: HK$772.9m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.48
7D
1.2%
1Y
1.6%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.6b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.07
7D
1.9%
1Y
-13.0%